| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-16 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |